News | Page 2
Daily news and information for physicians in a range of specialties and practice settings.
Great Risks: Youth Football Players Suffer More from Impairment, Depression
The study from researchers at the University of Boston School of Medicine was the first large-scale look into tackle football's effect on youths.
Ocrevus Wins in Cost-effectiveness Study, But Price Questions Remain
New research suggests Ocrevus saves money over subcutaneous interferon beta 1-a in the long run, though insurers say they need more data to get a clear picture of a drug’s value.
Researchers Develop 3-in-1 Antibodies for HIV/AIDS
Trispecific antibodies show exceptionally promising results against HIV.
Patisiran Met Primary Endpoints in Phase 3 Hereditary ATTR (hATTR) Amyloidosis
Alnylam Therapeutics expects to file for a New Drug Application in late 2017.
FDA Adjusts Stance on Buprenorphine, Methodone for Opioid Addiction
Buprenorphine and methadone — while linked to increased risk of serious side effects — are more beneficial than harmful when combined with benzodiazepines or other central nervous system depressants for opioid addiction care.
FDA Gives Nod to Updated Duodenoscope Design
The ED34-i10T model includes a single-use, detachable and disposable distal cap, a simplified interface, ergonomic and image quality improvements, and reduced length.
Hepatitis C Increases Miscarriages, Pregnancy Risks
HCV-positive women of childbearing age undergo premature ovarian deterioration, researchers wrote.
Adult ADHD Patients Want Longer Acting Medications
When asked about an ideal medication, most survey respondents said such a drug would last all day.
Omalizumab Asthma Trials Analyzed to Identify Best Responders
Analysis of omalizumab trials has identified asthma patients who are most likely to respond to treatment.
"Real World" Omalizumab Asthma Study Links Response to FeNO
Results from "real word" asthma treatment with omalizumab correspond to clinical trial findings and suggest that FeNO values can help predict treatment response.
<< Prev Page
Next Page >>
Scott Solomon, MD, and Alvin Chandra, MD: The PARADIGM-HF and QoL Trial
MAA for Migraine Treatment Erenumab Accepted for Review
Severely Obese Children Have Dangerously Increased Risk of Type 2 Diabetes
Daclizumab, DMTs, and Risky Multiple Sclerosis Treatments
Study: Red Meat and Heme Iron Linked to Type 2 Diabetes
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.